Clinical trial NCT02995629 - References

Proliferative Diabetic Retinopathy - High Risk — Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation

Citation(s)

•   Alvarez-Verduzco O, Garcia-Aguirre G, Lopez-Ramos Mde L, Vera-Rodriguez S, Guerrero-Naranjo JL, Morales-Canton V
  Reduction of fluence to decrease pain during panretinal photocoagulation in diabetic patients. Ophthalmic Surg Lasers Imaging. 2010 Jul-Aug;41(4):432-6. doi: 10.3928/15428877-20100525-02.
•   Chiu HH, Wu PC
  Manual acupuncture for relieving pain associated with panretinal photocoagulation. J Altern Complement Med. 2011 Oct;17(10):915-21. doi: 10.1089/acm.2010.0082.
•   Ko BW, Shim JH, Lee BR, Cho HY
  Analgesic effects of tramadol during panretinal photocoagulation. Korean J Ophthalmol. 2009 Dec;23(4):273-6. doi: 10.3341/kjo.2009.23.4.273.
•   Mainster MA
  Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems. Ophthalmology. 1986 Jul;93(7):952-8.
•   Mirshahi A, Lashay A, Roozbahani M, Fard MA, Molaie S, Mireshghi M, Zaferani MM
  Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1103-7. doi: 10.1007/s00417-012-2167-5.
•   Photocoagulation treatment of proliferative diabetic retinopathy
  Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981 Jul;88(7):583-600.
•   Richardson C, Waterman H
  Pain relief during panretinal photocoagulation for diabetic retinopathy: a national survey. Eye (Lond). 2009 Dec;23(12):2233-7. doi: 10.1038/eye.2008.421.
•   Tesha PE, Giavedoni LR, Berger AR, Altomare F, Chow DR, Navajas EV, Yoganathan P, Wong DT, Principe A
  Subconjunctival lidocaine before laser treatment: a randomized trial. Ophthalmology. 2010 Sep;117(9):1810-4. doi: 10.1016/j.ophtha.2010.01.036.
•   Vujosevic S, Martini F, Longhin E, Convento E, Cavarzeran F, Midena E
  SUBTHRESHOLD MICROPULSE YELLOW LASER VERSUS SUBTHRESHOLD MICROPULSE INFRARED LASER IN CENTER-INVOLVING DIABETIC MACULAR EDEMA: Morphologic and Functional Safety. Retina. 2015 Aug;35(8):1594-603. doi: 10.1097/IAE.0000000000000521.
•   Wu WC, Hsu KH, Chen TL, Hwang YS, Lin KK, Li LM, Shih CP, Lai CC
  Interventions for relieving pain associated with panretinal photocoagulation: a prospective randomized trial. Eye (Lond). 2006 Jun;20(6):712-9.
•   Yadav NK, Jayadev C, Mohan A, Vijayan P, Battu R, Dabir S, Shetty B, Shetty R; Medscape
  . Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye (Lond). 2015 Feb;29(2):258-64; quiz 265. doi: 10.1038/eye.2014.315.
•   Zakrzewski PA, O'Donnell HL, Lam WC
  Oral versus topical diclofenac for pain prevention during panretinal photocoagulation. Ophthalmology. 2009 Jun;116(6):1168-74. doi: 10.1016/j.ophtha.2009.01.022.

Patient Comfort Using Green (532 nm) Versus Yellow (577 nm) Laser Indirect Ophthalmoscopy Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Details for clinical trial NCT02995629